news
Pfizer details new costs to settle some litigation
13 May 2011 | By European Pharmaceutical Review
Pfizer will settle more than 2,200 lawsuits alleging the company's Wyeth unit hid Prempro's cancer risks...
List view / Grid view
Pfizer
news
Achieving Quality & Process Excellence in the Pharma Industry
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
news
Pfizer’s Prevnar 13® meets all study endpoints in two pivotal phase 3 trials in adults aged 50 and older
9 May 2011 | By Pfizer
Pfizer Inc. announced that the data from its two pivotal Phase 3 immunogenicity and safety trials of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine...
news
The European Commission approves Pfizer’s Revatio® (sildenafil)
5 May 2011 | By Pfizer
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission...
news
Pfizer comments on ORAL Sync tofacitinib data
25 April 2011 | By Pfizer Inc.
Pfizer has commented on an abstract concerning the ORAL Sync Phase 3 study of tofacitinib in patients with rheumatoid arthritis...
news
Pfizer and Shanghai Pharmaceutical sign memorandum of understanding for potential strategic partnership
20 April 2011 | By Pfizer
Shanghai Pharmaceutical Co. Ltd. and Pfizer Inc. today announced the signing of a MOU...
news
Pfizer announces top-line results of third phase 3 clinical trial of Tofacitinib (CP-690,550)
15 April 2011 | By Pfizer
Pfizer Inc. announced top-line results from the ORAL Scan Phase 3 study (A3921044)...
news
Social media and the pharma industry
11 April 2011 | By GDS International
Every other industry is getting on the social media bandwagon. But could social media actually prove beneficial to the world of pharma?...
news
immatics to receive support from Pfizer for its pivotal Phase III study (IMPRINT) with IMA901
11 April 2011 | By Citigate Dewe Rogerson Ltd
immatics, announced that Pfizer are to support its pivotal Phase III trial (IMPRINT) with IMA901...
news
AZ, Pfizer and GSK leaders endorse university’s Quality by Design course
28 March 2011 | By De Montfort University
De Montfort University’s unique QbD course received major endorsement by senior industry leaders when it was launched last week...
news
Can personalised medicine save the pharma sector?
17 March 2011 | By GDS International
Personalised medicine is making a comeback – but will it stick this time?...
news
PharmaChemical Ireland welcomes Amgen purchase of Pfizer’s Dublin facility
11 March 2011 | By PharmaChemical Ireland
PharmaChemical Ireland, welcomed the news that Amgen has agreed to purchase Pfizer’s manufacturing facility in Dun Laoghaire, Co Dublin...
news
Pfizer invites public to view and listen to webcast of Pfizer presentation at Healthcare Conference
10 March 2011 | By Pfizer
View and listen to a webcast of a presentation by Mikael Dolsten, President, Worldwide R&D...
news
Pfizer completes acquisition of King Pharmaceuticals, Inc.
1 March 2011 | By Pfizer
Pfizer completed its acquisition of King through the merger of its wholly owned subsidiary, Parker Tennessee Corp...
news
David Redfern appointed as new Chairman of ViiV Healthcare
25 February 2011 | By GlaxoSmithKline
GSK, ViiV Healthcare, & Pfizer announced the appointment of David Redfern as the new Chairman of the Board for ViiV Healthcare...
